APDN Applied DNA Sciences, Inc. Stock Quote

APDN [NASD]

Industrials | Security & Protection Services | USA

Index	-	P/E	-	EPS (ttm)	-3.43	Insider Own	13.83%	Shs Outstand	5.14M	Perf Week	-5.50%
Market Cap	30.47M	Forward P/E	-	EPS next Y	-1.67	Insider Trans	0.00%	Shs Float	4.88M	Perf Month	88.36%
Income	-13.00M	PEG	-	EPS next Q	-0.54	Inst Own	12.10%	Short Float	13.57%	Perf Quarter	39.24%
Sales	1.90M	P/S	16.04	EPS this Y	65.70%	Inst Trans	-	Short Ratio	0.81	Perf Half Y	2.52%
Book/sh	1.11	P/B	9.91	EPS next Y	0.60%	ROA	-109.70%	Target Price	13.50	Perf Year	160.66%
Cash/sh	2.82	P/C	3.91	EPS next 5Y	-	ROE	-179.70%	52W Range	2.52 - 16.39	Perf YTD	115.69%
Dividend	-	P/FCF	-	EPS past 5Y	33.30%	ROI	-156.70%	52W High	-32.89%	Beta	1.46
Dividend %	-	Quick Ratio	2.00	Sales past 5Y	-26.50%	Gross Margin	62.70%	52W Low	336.51%	ATR	1.18
Employees	59	Current Ratio	2.10	Sales Q/Q	-82.40%	Oper. Margin	-	RSI (14)	68.78	Volatility	17.06% 14.18%
Optionable	No	Debt/Eq	0.40	EPS Q/Q	44.30%	Profit Margin	-	Rel Volume	14.30	Prev Close	8.91
Shortable	Yes	LT Debt/Eq	0.09	Earnings	Dec 17 AMC	Payout	-	Avg Volume	814.57K	Price	11.00
Recom	2.00	SMA20	69.73%	SMA50	63.61%	SMA200	41.03%	Volume	11,651,318	Change	23.46%

Jan-14-21

Reiterated

H.C. Wainwright

Buy

$18 → $14

Dec-18-20

Reiterated

H.C. Wainwright

Buy

$20 → $12

Jul-20-20

Reiterated

H.C. Wainwright

Buy

$18 → $22

Jul-02-20

Initiated

H.C. Wainwright

Buy

$18

Nov-14-16

Reiterated

Maxim Group

Buy

$8 → $6

May-13-16

Reiterated

Maxim Group

Buy

$13 → $9

Oct-08-15

Reiterated

Maxim Group

Buy

$9 → $13

May-26-15

Initiated

The Benchmark Company

Speculative Buy

Feb-10-15

Reiterated

Maxim Group

Buy

$7 → $9

Jan-13-15

Initiated

Maxim Group

Buy

Jan-15-21 07:00AM	Applied DNA Provides Business Update on COVID-19 Diagnostics and Testing Business Wire +23.46%
Jan-13-21 11:44AM	Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Business Wire
Jan-12-21 09:52AM	New Strong Sell Stocks for January 12th Zacks
Jan-11-21 08:22PM	Applied DNA Sciences (APDN): Next Stop, $18? TipRanks -24.05%
10:25AM	ROCE Insights For Applied DNA Sciences Benzinga
07:00AM	Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Business Wire
Jan-08-21 01:43PM	U.S. FDA Lists Applied DNAs Linea COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7) Business Wire +104.93%
01:05PM	FDA identifies 3 COVID-19 tests that may be impacted by new variant MarketWatch
Jan-07-21 08:29AM	New Strong Sell Stocks for January 7th Zacks
Jan-05-21 08:00AM	Applied DNA to Participate in the H.C. Wainwright BIOCONNECT 2021 Conference Business Wire
Jan-04-21 08:00AM	Applied DNA Announces Preliminary Estimated First Fiscal Quarter 2021 Revenues in the Range of $1.3 Million to $1.6 Million Business Wire
Dec-29-20 10:58AM	Applied DNA Partners with CLEARED4 on Pooled COVID-19 Surveillance Testing Program Business Wire
Dec-18-20 09:44PM	New Strong Sell Stocks for December 18th Zacks -17.31%
Dec-17-20 05:35PM	Applied DNA Sciences (APDN) Reports Q4 Loss, Misses Revenue Estimates Zacks +6.67%
04:14PM	Recap: Applied DNA Sciences Q4 Earnings Benzinga
04:05PM	Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results Business Wire
02:30PM	Applied DNA Sciences, Inc. to Host Earnings Call ACCESSWIRE
01:10PM	Applied DNA Awarded Pooled Surveillance Testing Contract Valued at Up to $2.0 Million from Suffolk County (N.Y.) Government Business Wire
Dec-16-20 10:02AM	Applied DNA Sciences Earnings Preview Benzinga
Dec-11-20 08:00AM	Compliance with New York State Winter COVID-19 Plan Drives Demand for Applied DNAs Pooled Surveillance Testing Program Business Wire
Dec-08-20 09:00AM	Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST Business Wire
Dec-07-20 08:00AM	Nutrition21 Transitions to Applied DNAs CertainT® Platform to Secure IP-protected Portfolio of Dietary Supplement Ingredients Business Wire
Dec-01-20 08:00AM	Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball Business Wire
Nov-30-20 07:00AM	Applied DNA, EvviVax, and GVS Receive Regulatory Approval to Conduct Veterinary Clinical Trial for Linear COVID-19 Vaccine Candidate Business Wire
Nov-27-20 10:39AM	Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 Business Wire +6.69%
Nov-25-20 08:00AM	Applied DNA Significantly Expands Addressable Market for Linea COVID-19 Assay Kit via Successful Amendment to FDA EUA Business Wire
Nov-12-20 08:00AM	Applied DNA Secures Blanket Purchase Order for 10,000 Linea COVID-19 Tests Business Wire
Nov-10-20 07:00AM	Stony Brook University Hospital Launches COVID-19 Surveillance Testing Program Powered by Applied DNAs Assay Kit and Services Business Wire
Nov-02-20 08:00AM	Applied DNA Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications Business Wire -9.21%
Oct-30-20 08:00AM	Applied DNA to Increase COVID-19 Surveillance Testing Utility for its Linea COVID-19 Assay Kits Through Expanded Use of Robotic Automation Business Wire +12.55%
Oct-12-20 07:30AM	Applied DNA Secures $1.0+ Million in COVID-19 Surveillance Testing Annualized Revenue, Builds Sales Pipeline for Test Kit and Testing-as-a-Service Business Wire
Oct-08-20 09:00AM	Applied DNA Announces Repayment of Secured Convertible Notes Business Wire
Sep-29-20 09:40AM	Applied DNA Signs Master Services Agreement with Stony Brook University Hospital for COVID-19 Diagnostic Assay Kit and Automated Systems, Receives Initial Purchase Order Business Wire -6.47%
Sep-21-20 08:30AM	Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment Business Wire
Sep-16-20 04:00AM	Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate Business Wire
Sep-02-20 08:00AM	Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15 Business Wire
Aug-27-20 12:38PM	Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary Business Wire -14.63%
Aug-17-20 06:38AM	Is Applied DNA Sciences (NASDAQ:APDN) Using Too Much Debt? Simply Wall St.
06:00AM	Applied DNA Positions LinearDNA Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing Business Wire
Aug-12-20 08:00AM	Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging Business Wire -9.98%
Aug-06-20 04:05PM	Applied DNA Reports Fiscal Third Quarter 2020 Financial Results Business Wire
Aug-05-20 07:21PM	Stocks Showing Market Leadership: Applied Dna Sciences Earns 93 RS Rating Investor's Business Daily
Jul-31-20 11:13AM	Why Applied DNA Sciences' Stock Is Trading Higher Today Benzinga +14.81%
08:00AM	FDA Approves EUA Amendment Increasing Applied DNAs COVID-19 Diagnostic Kit Testing Capacity Through Use of Automated RNA Extraction and Expands Supported Platforms Business Wire
Jul-30-20 11:29AM	Applied DNA to Report Fiscal 2020 Third Quarter Financial Results After Market Close on August 6, 2020 Business Wire
Jul-17-20 07:41AM	The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient Benzinga +19.35%
06:20AM	Applied DNA and Takis Report Positive Preclinical Results from LineaDNA Vaccine Candidates for COVID-19 Business Wire
Jul-15-20 07:00AM	Applied DNA Appoints New Head of Investor Relations and Corporate Communications Business Wire
Jul-09-20 08:09AM	The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio Benzinga
05:00AM	Applied DNA Forms Clinical Testing Subsidiary to Maximize Utility of FDA EUA-Approved Linea COVID-19 Assay Kit and Expands Utility with Successful EUA Amendment Business Wire
Jul-02-20 01:08PM	Applied DNA Analyst Says Coronavirus Testing, Vaccine Work Could Drive Major Upside Benzinga +6.45%
Jun-26-20 07:00AM	Applied DNA Sciences Set to Join Russell Microcap Index Business Wire
Jun-12-20 08:53PM	Edited Transcript of APDN earnings conference call or presentation 14-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-09-20 11:33AM	Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates Business Wire
Jun-08-20 08:26AM	Applied DNA Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program Business Wire +6.79%
May-21-20 11:11AM	Applied DNA to Participate in Maxim Groups COVID-19 Virtual Conference Series on May 27 Business Wire
May-19-20 06:23AM	News Flash: One Applied DNA Sciences, Inc. (NASDAQ:APDN) Analyst Has Been Trimming Their Revenue Forecasts Simply Wall St.
May-16-20 08:15AM	Analysts Have Lowered Expectations For Applied DNA Sciences, Inc. (NASDAQ:APDN) After Its Latest Results Simply Wall St.
May-15-20 10:43AM	Applied DNA Sciences Tackles COVID-19 on Three Fronts; Analyst Says Buy TipRanks -26.96%
06:13AM	Those Who Purchased Applied DNA Sciences (NASDAQ:APDN) Shares Five Years Ago Have A 85% Loss To Show For It Simply Wall St.
May-14-20 04:34PM	Dow marks sharpest intraday comeback in 2 months, partly powered by a rally in battered banks MarketWatch +71.09%
04:05PM	Applied DNA Reports 2020 Fiscal Second Quarter Financial Results Business Wire
09:59AM	Applied DNA's Coronavirus Test Cleared by FDA for Emergency Use TheStreet.com
08:32AM	The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger Benzinga
07:12AM	Shares of Applied DNA Sciences jump 66% on regulatory authorization of its COVID-19 test MarketWatch
05:00AM	Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit Business Wire
May-07-20 08:00AM	Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET Business Wire -6.38%
May-06-20 08:00AM	Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise Business Wire +9.18%
May-05-20 09:32AM	Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit Business Wire -5.70%
May-04-20 03:00AM	Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals Business Wire +37.71%
Apr-30-20 05:25PM	Applied DNA Accepted Into U.S. FDAs Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging Business Wire +11.15%
Apr-21-20 08:19AM	The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives Benzinga +17.13%
02:00AM	Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital Business Wire
Apr-15-20 08:03AM	The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US Benzinga +26.59%
06:03AM	Applied DNA Ships COVID-19 LinearDNA Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing Business Wire
Apr-14-20 08:30AM	Applied DNA to Speak on COVID-19 Panel at Maxim Groups Infectious Disease Virtual Conference on May 5 Business Wire +12.62%
Apr-02-20 08:18AM	Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate Business Wire
Mar-31-20 06:35AM	Is Applied DNA Sciences, Inc. (NASDAQ:APDN) Excessively Paying Its CEO? Simply Wall St.
Mar-26-20 08:37AM	Applied DNA Ships LinearDNA to Another Development Customer Business Wire
Mar-24-20 08:20AM	The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test Benzinga
07:00AM	Applied DNA Files Provisional Patent Application for High Sensitivity COVID-19 Diagnostic Assay with U.S. Patent and Trademark Office Business Wire
Mar-20-20 11:29AM	Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer Business Wire -15.27%
Mar-19-20 07:00AM	Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection Business Wire -20.98%
Mar-18-20 03:04PM	Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models Business Wire +122.36%
Mar-04-20 09:48AM	3 Biotech Stocks Join the Coronavirus Fight TipRanks -7.95%
Mar-02-20 03:04PM	Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines For Animal Testing Benzinga +29.82%
07:51AM	Benzinga Pro's Top 5 Stocks To Watch For Mon., Mar. 2, 2020: GILD, BIDU, CODX, MRKR, APDN Benzinga
04:00AM	Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA Vaccine Candidates Designed Business Wire
Feb-24-20 09:00AM	Applied DNA Announces Receipt of International Patents on its Beacon® Secure Optical Molecular Marker Technologies Business Wire +6.46%
Feb-21-20 06:05PM	Edited Transcript of APDN earnings conference call or presentation 6-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-20-20 09:00AM	Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products Business Wire
Feb-19-20 10:33AM	Applied DNA Enters Dietary Supplements Market with Multi-Year Nutrition21 Contract Business Wire +6.53%
Feb-07-20 10:20AM	Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV Business Wire
09:00AM	Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials Business Wire
Feb-06-20 05:50PM	Applied DNA Reports 2020 Fiscal First Quarter Financial Results Business Wire
02:30PM	Applied DNA Sciences, Inc. to Host Earnings Call ACCESSWIRE
Jan-31-20 07:22AM	Who Has Been Buying Applied DNA Sciences, Inc. (NASDAQ:APDN) Shares? Simply Wall St.
Jan-30-20 05:00AM	Applied DNA Schedules Fiscal 2020 First Quarter Financial Results Conference Call for Thursday, February 6, 2020 at 4:30 PM ET Business Wire
Jan-27-20 09:00AM	Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials Business Wire
Jan-13-20 09:15AM	Applied DNA Subsidiary, LineaRx, Inc., Signs Licensing Agreement with LifeSensors, Inc. Business Wire +6.48%

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes applications in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications and can be used to fortify brand protection efforts, and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide definitive real-time authentication of molecular tags in the field; and CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and non-diagnostic COVID-19 pooled surveillance testing to detect instances of COVID-19 in defined populations under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Montgomery William W	ex 5% owner	Jun 26	Buy	5.25	110,000	577,500	245,000	Jun 26 06:47 PM
Montgomery William W	5% owner	Jun 18	Buy	5.25	40,000	210,000	215,000	Jun 18 06:14 PM
Montgomery William W	5% Owner	Jun 09	Buy	5.25	75,000	393,750	175,000	Jun 09 08:48 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience